BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8393241)

  • 1. A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus.
    Boerkoel CF; Federspiel MJ; Salter DW; Payne W; Crittenden LB; Kung HJ; Hughes SH
    Virology; 1993 Aug; 195(2):669-79. PubMed ID: 8393241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the gag region on genome stability: avian retroviral vectors that contain sequences from the Bryan strain of Rous sarcoma virus.
    Federspiel MJ; Hughes SH
    Virology; 1994 Sep; 203(2):211-20. PubMed ID: 8053145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on recombination in heterologous crosses of Rous sarcoma virus.
    Balduzzi PC; Christensen JR; Notter MF
    J Gen Virol; 1980 Sep; 50(1):173-8. PubMed ID: 6255082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ALV-based packaging cell lines for production of contaminant defective viruses.
    Girod A; Cosset FL; Verdier G; Ronfort C
    Virology; 1995 Jun; 209(2):671-5. PubMed ID: 7778301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete env gene deletions of three replication-defective strains of Rous sarcoma virus and a model for the origin of their genetic structures.
    Nunn M; Chan S; Duesberg PH
    Virology; 1984 Apr; 134(2):466-71. PubMed ID: 6100578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line.
    Ronfort C; Girod A; Cosset FL; Legras C; Nigon VM; Chebloune Y; Verdier G
    Virology; 1995 Feb; 207(1):271-5. PubMed ID: 7871738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of two transforming viruses from sarcomas obtained in chickens inoculated intraembryonally with a transformation defective mutant of Prague strain Rous sarcoma virus.
    Svoboda J; Geryk J; Karakoz I; Rejthar A
    Folia Biol (Praha); 1985; 31(2):135-51. PubMed ID: 2991028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of nondefective Rous sarcoma virus by asymmetric recombination between deletion mutants.
    Martin GS; Lee WH; Duesberg PH
    J Virol; 1980 Nov; 36(2):591-4. PubMed ID: 6253679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of env-deficient rous sarcoma virus (RSV) early after infection.
    Hara H; Park HT; Fujihara M; Kaji A
    Folia Biol (Praha); 1997; 43(2):63-70. PubMed ID: 9158953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
    J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and design of more effective avian replication-incompetent retroviral vectors.
    Chen CM; Smith DM; Peters MA; Samson ME; Zitz J; Tabin CJ; Cepko CL
    Dev Biol; 1999 Oct; 214(2):370-84. PubMed ID: 10525341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectors, promoters, and expression of genes in chick embryos.
    Chen HY; Garber EA; Mills E; Smith J; Kopchick JJ; DiLella AG; Smith RG
    J Reprod Fertil Suppl; 1990; 41():173-82. PubMed ID: 2170640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial characterization of rat cell lines infected by a Rous sarcoma virus-33.
    Blahová S; Kisseljova NP; Bies J; Kisseljov FL; Grófová M
    Folia Biol (Praha); 1992; 38(2):90-102. PubMed ID: 1326448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a molecular clone of a highly infectious avian leukosis virus.
    Bieth E; Darlix JL
    C R Acad Sci III; 1993 Aug; 316(8):754-62. PubMed ID: 8044699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of transgenic quails with high frequency of germ-line transmission using VSV-G pseudotyped retroviral vector.
    Mizuarai S; Ono K; Yamaguchi K; Nishijima K; Kamihira M; Iijima S
    Biochem Biophys Res Commun; 2001 Aug; 286(3):456-63. PubMed ID: 11511080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete nucleotide sequence of Rous sarcoma virus variants adapted to duck cells].
    Kashuba VI; Kavsan VM; Ryndich AV; Lazurkevich ZV; Zubak SV; Popov SV; Dostalova V; Glozhanek I
    Mol Biol (Mosk); 1993; 27(2):436-50. PubMed ID: 8387633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spread of a replication-competent MuLV retroviral vector can be efficiently blocked by deletion variants.
    Nouvel P; Panthier JJ; Condamine H
    Virology; 1994 Oct; 204(1):180-9. PubMed ID: 8091651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of helper cells with two host ranges to generate high-titer retroviral vectors.
    Cosset FL; Girod A; Flamant F; Drynda A; Ronfort C; Valsesia S; Molina RM; Faure C; Nigon VM; Verdier G
    Virology; 1993 Mar; 193(1):385-95. PubMed ID: 8382402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response and resistance to Rous sarcoma virus challenge of chickens immunized with cell-associated glycoproteins provided with a recombinant avian leukosis virus.
    Chebloune Y; Rulka J; Cosset FL; Valsesia S; Ronfort C; Legras C; Drynda A; Kuzmak J; Nigon VM; Verdier G
    J Virol; 1991 Oct; 65(10):5374-80. PubMed ID: 1654445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
    Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
    Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.